You just read:

Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma

News provided by

Blueprint Medicines

Sep 10, 2017, 10:30 ET